Targeting the Blood-Brain Barrier with Nano-Biomaterials DOI

Sanjay K. Gowda,

D. Venkataramanamma,

Rina Singh

и другие.

Опубликована: Янв. 1, 2024

Язык: Английский

Nanoscale drug formulations for the treatment of Alzheimer's disease progression DOI Creative Commons

Liu Liqin,

Haini He,

Bert N. La Du

и другие.

RSC Advances, Год журнала: 2025, Номер 15(6), С. 4031 - 4078

Опубликована: Янв. 1, 2025

Alzheimer's disease (AD) is a devastating neurodegenerative disorder with no effective disease-modifying treatments.

Язык: Английский

Процитировано

0

Quercetin carbon quantum dots: dual-target therapy for intracerebral hemorrhage in mice DOI Creative Commons
Guangyu Jia, Xinyu Yang, Yamei Yu

и другие.

Molecular Brain, Год журнала: 2025, Номер 18(1)

Опубликована: Март 3, 2025

Following intracerebral hemorrhage, mitigating oxidative stress and removing excess iron are critical strategies for reducing secondary brain injury improving neurological outcomes. In vitro, we synthesized quercetin-ethylenediamine carbon quantum dots (QECQDs) with diameters of 2-11 nm found that QECQDs effectively scavenge ABTS+· DPPH· free radicals, defending HT22 cells against hemin-induced stress. vivo, predominantly accumulate in the pia mater, subarachnoid space, dura mater after intrathecal injection. Compared to ICH group, treatment improves cerebral blood flow, inhibits damage, reduces neuron death. Importantly, reduced hemorrhage volume, alleviated edema, improved function. This lays a foundation developing multi-target drugs treating ICH.

Язык: Английский

Процитировано

0

ROS-related nanoparticles for the management of Alzheimer’s disease: Wielding the double-edged sword DOI

Yibin Yu,

Qi Zhang, Yihao Guo

и другие.

Chemical Engineering Journal, Год журнала: 2025, Номер unknown, С. 161784 - 161784

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Graphene Oxide Modified Microbubble for the Ultrasonic Imaging and Treatment of Hepatocellular Carcinoma DOI Creative Commons
Qi Zhou, Yuzhou Wang,

Qiwei Cheng

и другие.

ACS Applied Nano Materials, Год журнала: 2025, Номер unknown

Опубликована: Апрель 3, 2025

Язык: Английский

Процитировано

0

The review of nasal drug delivery system: The strategies to enhance the efficiency of intranasal drug delivery by improving drug absorption DOI
Shuhua Wei,

Zizhao Zhai,

Xi Kong

и другие.

International Journal of Pharmaceutics, Год журнала: 2025, Номер unknown, С. 125584 - 125584

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

A novel biomimetic nanovesicle containing caffeic acid-coupled carbon quantum dots for the the treatment of Alzheimer’s disease via nasal administration DOI Creative Commons

Yu Hu,

Jingwen Cui, Junpeng Sun

и другие.

Journal of Nanobiotechnology, Год журнала: 2024, Номер 22(1)

Опубликована: Окт. 19, 2024

Alzheimer's disease (AD) is a common neurodegenerative characterized by progressive cognitive and physical impairment. Neuroinflammation related to AD, the misfolding aggregation of amyloid protein in brain creates an inflammatory microenvironment. Microglia are predominant contributors neuroinflammation, abnormal activation microglia induces release large amount factors, promotes neuronal apoptosis, leads In this study, we used microglial membranes containing caffeic acid-coupled carbon quantum dots prepare novel biomimetic nanocapsule (CDs-CA-MGs) for treatment AD. The application CDs-CA-MGs via nasal administration can bypass blood‒brain barrier (BBB) directly target site inflammation. After with CDs-CA-MGs, AD mice showed reduced inflammation brain, decreased significantly improved learning memory abilities. addition, affect inflammation-related JAK-STAT Toll-like receptor signaling pathways mice. downregulated interleukins (IL-1β IL-6) tumor necrosis factor (TNF-α). This finding suggested that may improve impairment modulating responses. conclusion, use provides possible therapeutic strategy

Язык: Английский

Процитировано

3

Chances and challenges in intranasal administration delivery for brain disease treatment DOI Creative Commons
Shuyu Zheng, Yuanyuan Guo, Furong Yan

и другие.

Clinical and Translational Discovery, Год журнала: 2023, Номер 3(6)

Опубликована: Ноя. 15, 2023

Abstract In order to overcome the formidable challenges posed by intricate physiological barriers of brain, employment intranasal administration (INA) has emerged as an unconventional method for drug delivery, offering distinct advantages such non‐invasiveness and enhanced pharmacokinetic characteristics within brain. Primarily exploiting conduit offered olfactory and/or trigeminal nerve systems, INA route effectively delivers therapeutic agents. With introducing appropriate improvements formulation, incorporation nanocarriers, efficacious delivery via approach gained considerable traction treatment neurological disorders. This concise review highlights notable progress in explores potential modalities inherent this promising paradigm.

Язык: Английский

Процитировано

8

Application of carbon-based nanomaterials in Alzheimer's disease DOI
Mengyao Bai, Xu Shao, Chao Wang

и другие.

Materials Horizons, Год журнала: 2024, Номер unknown

Опубликована: Янв. 1, 2024

Alzheimer's disease (AD) is a chronic, progressive neurodegenerative disorder marked by permanent impairment of brain function across the whole brain. This condition results in deterioration cognitive patients and frequently associated with psychological symptoms such as agitation anxiety, imposing significant burden on both their families. Nanomaterials possess numerous distinctive physical chemical features that render them extensively utilized. In biomedical domain, nanomaterials can be utilized for prevention therapy, including medication delivery systems, biosensors, tissue engineering. article explores etiology potential molecular processes AD, well application carbon-based diagnosis treatment AD. Some are carbon quantum dots, nanotubes, graphene, among others. These materials physicochemical highly promising applications biosensing, drug delivery, neuroprotection, photothermal treatment. addition, this review explored various therapeutic approaches AD terms reducing inflammation, preventing oxidative damage, inhibiting Aβ aggregation. The advent nanotechnology has facilitated development novel disease. strategies provide early diagnosis, effective intervention neuroprotection

Язык: Английский

Процитировано

2

Continuous flow synthesis: A promising platform for the future of nanoparticle-based drug delivery DOI
Kampanart Huanbutta, Kittipat Suwanpitak, Nopphon Weeranoppanant

и другие.

Journal of Drug Delivery Science and Technology, Год журнала: 2023, Номер 91, С. 105265 - 105265

Опубликована: Дек. 16, 2023

Язык: Английский

Процитировано

6

Bio-Nano Synergy in Therapeutic Applications: Drug–Graphene Oxide Nanocomposites for Modulated Acetylcholinesterase Inhibition and Radical Scavenging DOI

Pynskhemborlang T. Phanrang,

Jahnabi Upadhyaya,

Asit K. Chandra

и другие.

The Journal of Physical Chemistry B, Год журнала: 2024, Номер 128(30), С. 7427 - 7437

Опубликована: Июль 18, 2024

The current study explores the synergistic application of biophysical chemistry and nanotechnology in therapeutic treatments, focusing specifically on development advanced biomaterials to repurpose FDA-approved Alzheimer's disease (AD) drugs as potent antioxidants. By integration AD into graphene oxide (GO) nanocomposites, an attempt enhance acetylcholinesterase (AChE) inhibition increase radical scavenging activity is proposed. This bionano synergy designed leverage unique properties both nanomaterial surface bioactive compounds, improving treatment effectiveness. nanocomposites also promise targeted drug delivery, GO can traverse blood-brain barrier inhibit AChE more effectively patients. Furthermore, drug-GO nanocomposite exhibits enhanced capabilities, offering additional benefits. elucidates a molecular level understanding how are modified when integrated with GO, enabling effective materials. interdisciplinary approach presented this exploits potential delivery systems achieve superior outcomes through synergy.

Язык: Английский

Процитировано

1